Nursing Elites

1. Which neurotransmitter is released by the sympathetic nervous system (SNS) to increase heart rate and the force of contraction of the heart?

• A. Norepinephrine
• B. Epinephrine
• C. Dopamine
• D. Acetylcholine

Correct answer: A

Rationale: The correct answer is Norepinephrine. Norepinephrine is the neurotransmitter released by the sympathetic nervous system that increases heart rate and the force of contraction. Epinephrine, though similar, is more involved in the fight-or-flight response and has a broader range of effects on various organs. Dopamine is not primarily responsible for increasing heart rate and contractility. Acetylcholine is a neurotransmitter that predominantly acts on the parasympathetic nervous system to decrease heart rate and contractility.

2. What is a condition where the heart's electrical impulses are delayed or blocked, leading to a slower or irregular heartbeat?

• A. Heart block
• B. Tachycardia
• C. Bradycardia
• D. Arrhythmia

Correct answer: A

Rationale: Heart block is the correct answer because it specifically refers to a condition where the heart's electrical impulses are delayed or blocked, resulting in a slower or irregular heartbeat. Tachycardia (choice B) is a condition characterized by a fast heart rate, Bradycardia (choice C) is a slow heart rate, and Arrhythmia (choice D) is a general term used to describe any abnormal heart rhythm, which may or may not involve delays or blocks in electrical impulses.

3. What is a device that delivers a fine spray of medication into the airways?

• A. Nebulizer
• B. Inhaler
• C. Oxygen concentrator
• D. Peak flow meter

Correct answer: A

Rationale: A nebulizer is a device that converts liquid medication into a fine mist, allowing it to be inhaled directly into the lungs. This makes it the correct answer to the question. Choice B, an inhaler, delivers medication in a different form - as a pressurized dose that needs to be inhaled. Choice C, an oxygen concentrator, is used to deliver oxygen to patients with breathing difficulties but does not deliver medication. Choice D, a peak flow meter, is used to measure how fast air can be blown out of the lungs and is not involved in delivering medication.

4. Which type of heart disease involves the stiffening of the heart muscle, reducing its ability to relax and fill with blood?

• A. Restrictive cardiomyopathy
• B. Hypertrophic cardiomyopathy
• C. Dilated cardiomyopathy
• D. Ventricular hypertrophy

Correct answer: A

Rationale: The correct answer is A, restrictive cardiomyopathy. This condition specifically involves the stiffening of the heart muscle, leading to a reduced ability to relax and fill with blood between beats. Choice B, hypertrophic cardiomyopathy, is characterized by abnormal thickening of the heart muscle, not stiffening. Choice C, dilated cardiomyopathy, involves the enlargement and weakening of the heart chambers, not stiffening. Choice D, ventricular hypertrophy, refers to the thickening of the walls of the heart's pumping chambers but does not specifically involve the stiffening that is characteristic of restrictive cardiomyopathy.

5. The client on spironolactone (Aldactone) has a potassium level of 5.8 mEq/L. What is the nurse’s priority action?

• A. Hold the spironolactone and notify the healthcare provider.
• B. Administer a potassium supplement.
• C. Continue the spironolactone as ordered.
• D. Increase the dose of spironolactone.

Correct answer: A

Rationale: With a potassium level of 5.8 mEq/L, which is high, the priority action for the nurse is to hold the spironolactone. Spironolactone is a potassium-sparing diuretic that can further increase potassium levels. Therefore, it is crucial to prevent exacerbating hyperkalemia by discontinuing the medication. Notifying the healthcare provider is necessary for further guidance and potential adjustments to the treatment plan. Administering a potassium supplement (Choice B) would be contraindicated since the client already has elevated potassium levels. Continuing the spironolactone as ordered (Choice C) can worsen hyperkalemia. Increasing the dose of spironolactone (Choice D) would be unsafe and exacerbate the high potassium levels.

Similar Questions